HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Reinhard Golz Selected Research
Reinhard Golz Research Topics
Disease
6
Neoplasms (Cancer)
07/2022 - 06/2009
4
Prostatic Neoplasms (Prostate Cancer)
02/2015 - 06/2009
2
Non-Muscle Invasive Bladder Neoplasms
07/2022 - 08/2021
2
Carcinoma (Carcinomatosis)
07/2022 - 04/2016
1
Adenocarcinoma
04/2016
1
Neoplasm Metastasis (Metastasis)
02/2015
1
Disease Progression
02/2015
Drug/Important Bio-Agent (IBA)
3
Prostate-Specific Antigen (Semenogelase)
IBA
02/2015 - 06/2009
2
Capsules (Microcapsules)
IBA
08/2014 - 06/2009
1
enfortumab vedotin
IBA
07/2022
1
Immunoconjugates (Immunoconjugate)
IBA
07/2022
1
Biomarkers (Surrogate Marker)
IBA
08/2021
1
Phenobarbital (Luminal)
FDA Link
08/2021
1
Nucleotides
IBA
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
DNA (Deoxyribonucleic Acid)
IBA
01/2021
1
Androgen Receptors (Androgen Receptor)
IBA
04/2016
1
Keratin-7 (Cytokeratin 7)
IBA
04/2016
1
Paraffin
IBA
04/2016
1
Uroplakin II
IBA
04/2016
1
Catenins
IBA
04/2016
1
Formaldehyde (Formol)
FDA Link
04/2016
1
Cadherins (E-Cadherin)
IBA
04/2016
1
Hormones (Hormone)
IBA
02/2015
1
2- (3- (2- aminoethyl)- 1H- indol- 5- yloxy)acetyl- L- tyrosyl- glycinamide (IS 159)
IBA
08/2014
Therapy/Procedure
4
Prostatectomy (Retropubic Prostatectomy)
02/2015 - 06/2009
2
Therapeutics
01/2021 - 02/2015
2
Radiotherapy
02/2015 - 08/2014
2
Adjuvant Radiotherapy
08/2013 - 06/2009